TSX closed
Loading markets…

Advertisement

Stocks/TSX/CRDL

Cardiol Therapeutics Inc Class A (CRDL : TSX)

Common Stock

$1.76

CAD

+0.05 (2.92%)

Last updated: 2026-07-31

Get CRDL alerts:

CRDL

Cardiol Therapeutics Inc Class A

Source:WealthAwesomeWealthAwesome
$0.26 (16.94%)
30 day period
$1.44$1.63$1.82Jun 19Jul 13Jul 31

Performance

1 Day

+0.00%

1 Week

+7.32%

1 Month

+15.03%

YTD

+29.41%

Key Statistics

Market Cap

$202.88M

52W High

$2.33

52W Low

$1.23

P/E Ratio

-

50 Day MA

$1.60

200 Day MA

$1.55

Beta

0.51

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Above 50 SMA

Price vs 200-Day SMA

Above 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
7/31/2026$1.72$1.80$1.70$1.76$1.76153,900
7/30/2026$1.65$1.73$1.61$1.71$1.71138,783
7/29/2026$1.68$1.70$1.61$1.63$1.6389,426
7/28/2026$1.64$1.72$1.57$1.70$1.70165,965
7/27/2026$1.68$1.70$1.63$1.64$1.64111,361
7/24/2026$1.74$1.74$1.64$1.67$1.6791,829
7/23/2026$1.79$1.85$1.72$1.74$1.74104,939
7/22/2026$1.79$1.82$1.74$1.82$1.82110,138
7/21/2026$1.76$1.82$1.73$1.77$1.7794,737
7/20/2026$1.76$1.81$1.65$1.75$1.75136,772

Analyst Price Targets

Based on analyst covering CRDL

📈

Wall Street analysts forecast CRDL stock price to rise 240.9% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$6.00

+240.9% Upside

Current Price

C$1.76

Last close

Compare analyst targets across the TSX & TSXV →

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on CRDL's historical volatility

HistoricalForecast68%95%
C$0.84C$1.34C$1.84C$2.34C$2.84C$3.34TodayMar 25May 29Jul 31Sep 12Oct 26Dec 8

30-Day Vol

55.4%

Annualized

90-Day Vol

59.6%

Annualized

Trend (90d)

-14.1%

Annualized drift

90d Mean

C$1.67

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$1.73C$1.43C$2.10
60 trading daysC$1.70C$1.30C$2.23
90 trading daysC$1.67C$1.20C$2.33

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Cardiol Therapeutics Inc Class A

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-35.57M
Profit Margin
0.00%
ROE (TTM)
-173.96%
EPS (Diluted)
-0.39
Book Value
0.22

Classification

Sector
Health Care
Industry
Pharmaceuticals
Group
Pharmaceuticals, Biotechnology & Life Sciences

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About CRDL

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
ADCOAdcore Inc$0.14+0.00%
APLIAppili Therapeutics Inc$0.01+0.00%
ASCUArizona Sonoran Copper Company Inc$8.06+0.00%
ATCUAlta Copper Corp.$1.39+0.00%
AX-UNArtis Real Estate Investment Trust$25.61+0.00%
BBU-UNBrookfield Business Partners L.P.$45.79+0.00%
BITFBitfarms Ltd$8.24+0.00%
BNGBengal Energy Ltd$0.02+0.00%

CRDL.TO news timeline

15 articles covering CRDL.TO, most recent first

Latest

What's Going On With Cardiol Therapeutics Inc Class A Stock Tuesday?

Stocks

Advertisement